These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 13070457)

  • 1. [Fatal uremia after triethylenemelamine treatment in chronic lymphatic leukemia].
    MARTIN H
    Klin Wochenschr; 1953 Mar; 31(11-12):263-6. PubMed ID: 13070457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Triethylenemelamine (TEM) in lymphatic leukemia].
    PRIBILLA W; STOLLBERG G
    Munch Med Wochenschr; 1954 Oct; 96(41):1189-91. PubMed ID: 13223716
    [No Abstract]   [Full Text] [Related]  

  • 3. The immediate action of triethylene melamine in chronic lymphatic leuchaemia.
    BOLTON JH; BEAN RH
    Med J Aust; 1954 Sep; 2(12):474-8. PubMed ID: 13213377
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thirty cases of chronic leukemic lymphadenosis treated with intravenous administration of triethylene melamine].
    GIGANTE D; ZOPPINI A
    Prog Med (Napoli); 1956 Jun; 12(12):361-8. PubMed ID: 13350408
    [No Abstract]   [Full Text] [Related]  

  • 5. Some clinical experience in the use of triethylene melamine (TEM).
    HAMERMAN DJ; MELAMED S
    J Mt Sinai Hosp N Y; 1953; 20(1):16-26. PubMed ID: 13061942
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical use of triethylene melamine.
    KRAVITZ SC; DIAMOND HD; CRAVER LF
    Blood; 1952 Jul; 7(7):729-42. PubMed ID: 14934758
    [No Abstract]   [Full Text] [Related]  

  • 7. Triethylene melamine in the treatment of neoplastic disease.
    RUNDLES RW; BARTON WB
    Blood; 1952 May; 7(5):483-507. PubMed ID: 14925143
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hemoblastosis with triethylene melamine].
    LINKE A; LASCH HG
    Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
    [No Abstract]   [Full Text] [Related]  

  • 9. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.
    HAMBLY CK; ROBERTSON TI
    Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982
    [No Abstract]   [Full Text] [Related]  

  • 10. [Additional occurrence of carcinoma in a malignant disease treated with triethylene melamine].
    LUHRS W; SCHAMMEL J; LOTZ HH
    Z Gesamte Inn Med; 1954 Mar; 9(6):295-9. PubMed ID: 13170253
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trials with triethylene melamine].
    FERRARI M; KASDORF H
    Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952
    [No Abstract]   [Full Text] [Related]  

  • 12. [Considerations on a case of leukosarcomatosis].
    FUSCO FA
    Arch Maragliano Patol Clin; 1956 Jun; 12(3):499-532. PubMed ID: 13363614
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our experience with the application of triethylene melamine (TEM) in patients with malignant hemopathies].
    RUVIDIC R; NIKOLIC J
    Med Glas; 1960 Sep; 14():435-42. PubMed ID: 13744964
    [No Abstract]   [Full Text] [Related]  

  • 14. TREATMENT OF CHRONIC LEUKEMIC LYMPHOCYTIC LEUKEMIA WITH TRIETHYLENE MELAMINE (TEM) AND CHLORAMBUCIL (CB-1348).
    BIGLEY RH
    Cancer Chemother Rep; 1963 Jul; 30():27-30. PubMed ID: 14051500
    [No Abstract]   [Full Text] [Related]  

  • 15. Uremia complicating leukemia chemotherapy; report of a case treated with triethylene melamine.
    KRAVITZ SC; DIAMOND HD; CRAVER LF
    J Am Med Assoc; 1951 Aug; 146(17):1595-7. PubMed ID: 14861004
    [No Abstract]   [Full Text] [Related]  

  • 16. Myleran and triethylene melamine in the treatment of chronic granulocytic leukemia.
    BETHELL FH
    Ann N Y Acad Sci; 1958 Apr; 68(3):996-1000. PubMed ID: 13627746
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of malignant diseases of the blood with cortisone, triethylene melamine and the trace elements].
    DUBOIS-FERRIERE H
    Schweiz Med Wochenschr; 1951 Dec; 81(50):1235-7. PubMed ID: 14913076
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of triethylene melamine in treatment of leukemia and leukosarcoma.
    SILVERBERG JH; DAMESHEK W
    J Am Med Assoc; 1952 Mar; 148(12):1015-21. PubMed ID: 14897704
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].
    NEUMANN C
    Klin Wochenschr; 1952 Dec; 30(47-48):1105-8. PubMed ID: 13023980
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of leukemia and lymphomata with triethylene melamine.
    WALSH JR; PRATT PT; GRAHAM WE; ZIMMERMAN HJ
    Acta Haematol; 1954 Jun; 11(6):329-38. PubMed ID: 13170978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.